Literature DB >> 12948774

Multidrug-exporting secondary transporters.

Satoshi Murakami1, Akihito Yamaguchi.   

Abstract

The major cause of intrinsic drug resistance in Gram-negative bacteria is a resistance nodulation division type multidrug exporter, which couples with an outer membrane channel and a membrane fusion protein and exports drugs out of the cell, bypassing the periplasm; this process is driven by proton motive force. A recent crystal structure determination of a major resistance nodulation division type multidrug exporter, AcrB in Escherichia coli, greatly advances our understanding of the multidrug export mechanism. The most striking feature of the AcrB trimer is the presence of three vestibules open to the periplasm at the boundary between the periplasmic headpiece and the transmembrane region. Substrates can gain access to the central cavity from the periplasmic surface of the cytoplasmic membrane and are then actively transported through the extramembrane pore into the outer membrane channel TolC, via the funnel at the top of the AcrB headpiece.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12948774     DOI: 10.1016/s0959-440x(03)00109-x

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  29 in total

1.  Structure of the periplasmic component of a bacterial drug efflux pump.

Authors:  Matthew K Higgins; Evert Bokma; Eva Koronakis; Colin Hughes; Vassilis Koronakis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-28       Impact factor: 11.205

2.  Characterization of a resistance-nodulation-cell division transporter system associated with the syr-syp genomic island of Pseudomonas syringae pv. syringae.

Authors:  Hyojeung Kang; Dennis C Gross
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

Review 3.  Vacuuming the periplasm.

Authors:  Olga Lomovskaya; Maxim Totrov
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

4.  Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.

Authors:  Christopher A Elkins; Lisa B Mullis
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

5.  Protein modulator of multidrug efflux gene expression in Pseudomonas aeruginosa.

Authors:  Denis M Daigle; Lily Cao; Sebastien Fraud; Mark S Wilke; Angela Pacey; Rachael Klinoski; Natalie C Strynadka; Charles R Dean; Keith Poole
Journal:  J Bacteriol       Date:  2007-06-01       Impact factor: 3.490

6.  Crystal structure of the multidrug efflux transporter AcrB at 3.1A resolution reveals the N-terminal region with conserved amino acids.

Authors:  Debanu Das; Qian Steven Xu; Jonas Y Lee; Irina Ankoudinova; Candice Huang; Yun Lou; Andy DeGiovanni; Rosalind Kim; Sung-Hou Kim
Journal:  J Struct Biol       Date:  2006-12-24       Impact factor: 2.867

Review 7.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

8.  Structures of intermediate transport states of ZneA, a Zn(II)/proton antiporter.

Authors:  John Edward Pak; Elisabeth Ngonlong Ekendé; Efrem G Kifle; Joseph Daniel O'Connell; Fabien De Angelis; Meseret B Tessema; Kheiro-Mouna Derfoufi; Yaneth Robles-Colmenares; Rebecca A Robbins; Erik Goormaghtigh; Guy Vandenbussche; Robert M Stroud
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-30       Impact factor: 11.205

9.  β-Lactam selectivity of multidrug transporters AcrB and AcrD resides in the proximal binding pocket.

Authors:  Naoki Kobayashi; Norihisa Tamura; Hendrik W van Veen; Akihito Yamaguchi; Satoshi Murakami
Journal:  J Biol Chem       Date:  2014-02-20       Impact factor: 5.157

10.  AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar typhimurium DT104.

Authors:  Sylvie Baucheron; Shaun Tyler; David Boyd; Michael R Mulvey; Elisabeth Chaslus-Dancla; Axel Cloeckaert
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.